Notably, HS coexists with other inflammatory diseases where IL-6 also contributes to the development, including pyoderma gangrenosum and inflammatory bowel diseases, suggesting that they share similar immune–pathogenic pathways [99]. Here, IL6 is linked to inflammatory bowel disease.